Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited)

v3.20.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Income Statement [Abstract]    
NET REVENUE $ 21,867,169 $ 15,080,211
OPERATING EXPENSES:    
Direct operating costs 13,566,730 9,847,540
Selling and marketing 1,581,353 361,399
General and administrative 5,592,725 4,162,076
Research and development 2,333,126 254,656
Change in contingent consideration   (64,203)
Depreciation and amortization 1,332,786 756,740
Impairment charges 297,651
Total operating expenses 24,704,371 15,318,208
OPERATING LOSS (2,837,202) (237,997)
OTHER:    
Interest income 37,757 78,200
Interest expense (117,545) (95,396)
Other income (expense) - net 445,143 (81,030)
LOSS BEFORE PROVISION FOR INCOME TAXES (2,471,847) (336,223)
Income tax provision (benefit) 29,923 (40,532)
NET LOSS (2,501,770) (295,691)
Preferred stock dividend 2,642,916 1,492,700
NET LOSS ATTRIBUTABLE TO COMMON SHAREHOLDERS $ (5,144,686) $ (1,788,391)
Net loss per common share: basic and diluted $ (0.42) $ (0.15)
Weighted-average common shares used to compute basic and diluted loss per share 12,310,818 11,946,003